HCMT/MM2401
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HCMT/MM2401, covering 2025-09-02 to 2025-09-02. Get the full timeline:
Most recent: Clinical Trial Update: HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM [Phase 2]